Home » Topics » Disease categories and therapies » Immune

Immune
RSS

SangStat files NDA in Canada for Thymoglobulin

March 17, 2000

Isotechnika receives Canadian approval for human testing of immunosuppressive drug

March 16, 2000

3M's new immunomodulators induce TNF-alpha, IFN-alpha biosynthesis, inhibit Th2 immune response

March 15, 2000

Dynavax's ragweed immunotherapy has improved safety according to preclinical and clinical data

March 9, 2000

Prostanoid receptor ligands with selectivity for EP4 receptors designed by Ono researchers

March 9, 2000

White House teams up with industry to launch the Millennium Vaccine Initiative

March 9, 2000

Aerosol route preferred for measles vaccination campaign

March 7, 2000

Induction therapy with daclizumab in cardiac transplant recipients safe and effective

March 3, 2000

U.K.'s MCA approves another new meningitis C vaccine

March 2, 2000

Celgene accelerates development of second-generation compounds from the thalidomide class

March 1, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...